Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
http://www.globenewswire.com/news-release/2020/06/09/2045848/0/en/Revive-Therapeutics-Provides-Update-on-Discussions-with-Health-Canada-in-Pre-CTA-Meeting.html?ev=1
June 09, 2020 12:06 ET
Revive Therapeutics Provides Update on Discussions with Health Canada in Pre-CTA Meeting
TORONTO, June 09, 2020 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that the Company met with Health Canada in a Pre-Clinical Trial Application (“Pre-CTA”) meeting to evaluate the potential of a clinical study of Bucillamine in the treatment of patients with mild-moderate COVID-19 due to the SARS-CoV-2 infection in Canada.
The Pre-CTA meeting provided an opportunity for Revive to discuss Bucillamine’s scientific rationale of its potential use in the treatment of COVID-19 infections, Chemistry, Manufacturing and Controls, non-clinical and clinical safety information, and clinical trial design. Health Canada provided valuable guidance on the proposed clinical study design and information required for the submission of a complete CTA package. The aim of the Company is to file its Investigational New Drug (“IND”) package to the U.S. Food and Drug Administration (“FDA”) for the proposed Phase 3 confirmatory clinical trial (“Phase 3 study”) this month and the Company also now intends to follow up with the submission of the complete CTA package for Health Canada around this Phase 3 study as part of the same multinational clinical strategy.
“We were pleased with our discussions with Health Canada at the pre-CTA meeting which provided us with valuable guidance on the clinical study design and information that is required for the submission of the complete CTA package,” said Michael Frank, Revive’s Chief Executive Officer. “We are focused on advancing Bucillamine as a potential treatment for COVID-19, and the submission of our FDA IND application for our Phase 3 clinical study will form the foundation for our multinational clinical plans including Canada."
The Company is not making any express or implied claims that its product has the ability to eliminate or cure COVID-19 (or SARS2 Coronavirus) at this time.
What exactly does Sunshine Biopharma have? You've indicated on other boards about how they have a "COVID killer drug".
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=157425110
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=157425215
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=157425265
Please, enlighten us.
According to Sunshine's website involving "Drugs In Development - Anitviral Drugs", they only show that they've filed a "patent application for a new coronavirus COVID-19 treatment".
Where is the drug's development?
No, you don't know for a FACT. You simply get over excited over things when you should really just take a deep breath and calm down.
What you stated is 100% correct. Oh, wait...i'm the one who actually stated this, not you.
https://www.boardpost.net/forum/index.php?topic=15340.msg283673#msg283673
Next time don't play my words off as if they're yours.
Now, you're starting to think like Berman.
Escrow money...weeeeeeeeeeeeeeeeee!!!!
Keep up the brilliant DD, Royal Dud.
Is this the "tell" that AZCowboy has been talking about?
More money for our Escrows!!! Soon, we will experience our HLCE.
Check this out Royal, Apple is also involved. Our Escrow money.
"On May 11, 2020, Apple Inc. (“Apple”) consummated the issuance and sale of $2,000,000,000 aggregate principal amount of its 0.750% Notes due 2023 (the “2023 Notes”), $2,250,000,000 aggregate principal amount of its 1.125% Notes due 2025 (the “2025 Notes”), $1,750,000,000 aggregate principal amount of its 1.650% Notes due 2030 (the “2030 Notes”) and $2,500,000,000 aggregate principal amount of its 2.650% Notes due 2050 (the “2050 Notes” and, together with the 2023 Notes, the 2025 Notes and the 2030 Notes, the “Notes”), pursuant to an underwriting agreement (the “Underwriting Agreement”) dated May 4, 2020 among Apple and Goldman Sachs & Co. LLC, BofA Securities, Inc., J.P. Morgan Securities LLC and Morgan Stanley & Co. LLC, as representatives of the several underwriters named therein.
The Notes are being issued pursuant to an indenture, dated as of November 5, 2018 (the “Indenture”), between Apple and The Bank of New York Mellon Trust Company, N.A., as trustee, together with the officer’s certificate, dated May 11, 2020 (the “Officer’s Certificate”), issued pursuant to the Indenture establishing the terms of each series of Notes. "
https://www.sec.gov/ix?doc=/Archives/edgar/data/320193/000119312520139112/d926511d8k.htm
By the way, i think it's better that RVVTF didn't hugely gap up when it begin trading this morning. IMO, it's better for the share price to walk it's way up.
Stair steps...it's better because the share price will be making higher lows. Get rid of the weak hands on it's way up.
If you look at the chart for HGEN the share price didn't really start to take off till after they made an announcement of equity financing. IMO, i believe the market is waiting for RVVTF to make an announcement that they've obtained funding before they let the share price really fly.
Wow! So, DECN, Berman, needs shareholder's help...the same shareholders he's been screwing over for years and will continue to screw over for the foreseeable future? LOL.
Where's Large Green? Large Green needs to let everyone know that shareholder's equity = $11.85 a share.
I'm in for 370K shares.
Another example...Humanigen, Inc. (HGEN)
On June 2nd they announced equity financing for their phase III trial.
BOOM! The share price was off to the races.
IMHO, the jump in share price will happen upon the announcement of the company that the FDA has given Revive the green light to proceed with their phase III trials.
I believe the Market is also waiting for Revive to announce that they've secured funding.
Take a look at the chart of CYDY. On March 31st, they announced that the FDA had given them the green light to proceed with phase II trial. Also that same day, in a different PR, CYDY announced that they completed a non-dilutive convertible note financing.
By the way, if you look at the PPS days before their PR announcements you'll see that the share price increased. Someone knew of the pending news.
In my opinion, conservatively speaking, at a minimum should be $2.00. And, that's a 1000% gain from where the PPS is right now.
And, i believe this minimum will be reached on just the announcement that the company has proceeded with it's phase III trials.
All in my opinion.
NO! This has nothing to do with Escrow holders of Class 19 or Class 22.
This has to do with what is still owed to General Creditors, Senior Debt Holders, and Subordinated Debt Holders.
My thoughts and opinions about next week, specifically starting Monday.
On March 18th of this year the Company announced a private placement, the Offering. Pursuant to the Offering, the buyers have a statutory hold period of four months and one day, a ‘lockdown’ period. Starting Monday will be the first open market day in which the ‘lockdown’ period will no longer be in effect. The buyers to the Offering will be free to sell their shares if they choose to do so. As such, it may put downward pressure on the share price.
If so, we might see a great buying opportunity unless the company releases some news that morning which would see the PPS gap up.
This Monday we should see a great buying opportunity unless the company releases some news that morning.
Reality
PDF page 28 of 63
"21.During our first interview with Berman, he said that he noticed that Division staff had visited the DECN website."
"22.The following photograph was taken from DECN’s website available at:"
I won't post the link provided by the SEC but did anyone else notice that the link supplied could lead to DECN's open directory?
C'mon, the message sounded much better when you were stating " $3.00-$4.00 by the end of summer".
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156594624
Fress, what's the latest word from your friend who is a "Pharma analyst at Goldman Sachs"?
Anything under .50 is a gift, ~~ Per your own words ~~.
("Anything under .50 is a gift.
Multi Dollars in the coming weeks and months.
$10:00-$20.00 on Approval in 2020.")
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156654083
IMO, the fall was because of profit takers. (right?)
On June 30th the PPS closed at $.2124.
On July 1st the PPS opened at .$42 (that's 100% higher)
It also left an open gap that 95% of the time usually gets filled. So, it did...on July 2nd.
You show the level of your intelligence by believing that Royal Dud provides "great DD".
Don’t fret. Perhaps you could look back at some of your most recent postings if you need some positive encouragement that things will be ok?
Here, let me help get you started.
~~ Per your own words. ~~
{“Low side affects with historical Data on positive outcomes with patients lungs who have pneumonia RVVTF Bucillamine drug is going to be a game changer for tens of millions of people around the world. Billion dollar market cap in the making don't listen to these experts who can't read chart and nothing about a drugs value on treatment for Covid-19. These people are here to steal your shares.”}
{“price target $10.00 by end of summer. My friend is a Pharma analyst at Goldman Sachs. He says if Approval on RVVTF Bucillamine comes for Covid-19. At hits current market cap. The price valuations will between $20.00-$30.00.”}
{“Anything under .50 is a gift.
Multi Dollars in the coming weeks and months.”}
{“Don't sell for pennies sell for double digit dollars!”}
{“I hope people hold up for double digit dollars. Depending on how many shares you own. People will be able to retire with a nice chunk of cash in the bank. I think we see $10.00-$20.00 Plus by Q1 2021 5000% ROI from todays currents levels.”}
{“We are sitting on a goldmine here.”}
{“$3.00-$4.00 by the end of summer.”}
{“Fortunes to be made here on RVVTF.”}
What? After all your pumping, telling everyone to hold for dollars, you now have doubts about RVVTF?
You never answered my question.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156601574
First look at DECN's newest test to detect the COVID19 virus? Just as accurate as it's GenViro Swift test but with results in just 2.5 seconds?
http://lamcdn.net/hopesandfears.com/post-cover/2ysvBXMxJaAQzUVeSUBj7A-default.gif
How does it work? Do you shake it up like a magic 8 ball in order to give a random answer of "Not Present" or "Present"? LOL
Trying to fill the gap from yesterday, imo.
The warrants gave KKR the right to purchase 61,400,000 common shares at a predetermined strike price. Obviously they chose to purchase only 21,197,619 common shares instead.
It's likely that the stock has been halted for news that RVVTF will announce that it has filed an IND for it's proposed Phase 3 trial.
"Additionally, Revive is finalizing its IND with the U.S. FDA for the proposed Phase 3 confirmatory clinical trial to evaluate Bucillamine in the treatment of patients with mild-moderate COVID-19 due to the SARS-CoV-2 infection. The Company will file the IND later this month and expects final approval to proceed to the Phase 3 study shortly thereafter."
You really believe that RVVTF could see a MC of +3.1B?
"The market was closed when we received your order. It has been entered into our system and will be reviewed prior to market open on the next regular trading day. After market opens please check to make sure your order was accepted."
Yep, keep false hope alive.
Judge Mary Walrath: Well, why don’t we leave the Escrow Markers in place?
Brian Rosen: Again, your Honor, that could be done, but that will just lead the people once again, retail equity as Ms. Griffin refers to them, believing when they see something in their account that they’re going to be getting a distribution.
Judge Mary Walrath: Well, but…
Brian Rosen: Your Honor, Mr. Smith suggests that we leave the Escrow Markers in place and we’ll put an FAQ on the Trust website explaining what value they may have, which will be no purpose whatsoever, but we’ll do that, your Honor. We’ll leave the Markers there.
No need to guess, i did the calculation work about 6 months ago.
The grand total is $359,322,359.60
Various periods 9/26/08 - 3/19/12 (Total compensation for all entities or persons during this period is $271,085,212.87 million)
http://www.kccllc.net/wamu/document/0812229120801000000000003
==================================================================
AMOUNTS PAID BY WMI LIQUIDATING TRUST PURSUANT TO THE LIQUIDATING TRUST AGREEMENT FOR CERTAIN COMPENSATION AND FOR SERVICES RENDERED AND EXPENSES – for the periods covered between 3/1/12 to 8/31/19
3/19/12 - 5/31/12 $3,572,092.16
http://www.kccllc.net/wamu/document/0812229120730000000000007
3/19/12 – 8/31/12 $9,261,919.18
http://www.kccllc.net/wamu/document/0812229121022000000000005
3/19/12 – 11/30/12 $5,827,590.00
http://www.kccllc.net/wamu/document/0812229130125000000000003
3/1/12 – 2/28/13 $3,650,694.10
http://www.kccllc.net/wamu/document/0812229130425000000000019
3/1/12 – 7/31/13 $9,632,818.49
http://www.kccllc.net/wamu/document/0812229130719000000000019
4/1/13 – 8/31/13 $3,930,215.32
http://www.kccllc.net/wamu/document/0812229131028000000000001
3/19/12 – 11/30/13 $5,985,633.50
http://www.kccllc.net/wamu/document/0812229140129000000000001
9/1/13 – 2/28/14 $7,120,254.51
http://www.kccllc.net/wamu/document/0812229140428000000000005
1/1/14 – 5/30/14 $8,494,599.20
http://www.kccllc.net/wamu/document/0812229140722000000000001
4/1/14 – 8/31/14 $2,552,664.88
http://www.kccllc.net/wamu/document/0812229141021000000000001
7/1/14 – 11/30/14 $2,787,226.21
http://www.kccllc.net/wamu/document/0812229150116000000000001
10/1/14 – 2/28/15 $2,762,403.86
http://www.kccllc.net/wamu/document/0812229150407000000000001
12/1/14 – 5/31/15 $1,829,448.53
http://www.kccllc.net/wamu/document/0812229150715000000000002
10/1/14 – 8/31/15 $1,842,094.09
http://www.kccllc.net/wamu/document/0812229151109000000000001
6/1/15 – 11/30/15 $1,427,640.67
http://www.kccllc.net/wamu/document/0812229160208000000000001
10/1/15 – 2/29/16 $1,213,416.82
http://www.kccllc.net/wamu/document/0812229160421000000000001
1/1/16 – 5/31/16 $1,355,801.38
http://www.kccllc.net/wamu/document/0812229160728000000000003
5/1/16 – 8/31/16 $1,085,337.43
http://www.kccllc.net/wamu/document/0812229161025000000000002
4/1/16 – 11/30/16 $843,822.43
http://www.kccllc.net/wamu/document/0812229170118000000000002
10/1/16 – 2/28/17 $1,810,053.63
http://www.kccllc.net/wamu/document/0812229170425000000000001
2/1/17 – 5/31/17 $1,416,409.00
http://www.kccllc.net/wamu/document/0812229170719000000000001
5/1/17 – 8/31/17 $1,272,271.06
http://www.kccllc.net/wamu/document/0812229171018000000000023
7/1/17 – 11/30/17 $1,105,771.94
http://www.kccllc.net/wamu/document/0812229180122000000000001
7/1/17 – 2/28/18 $912,971.83
http://www.kccllc.net/wamu/document/0812229180419000000000002
2/1/18 – 5/31/18 $733,473.39
http://www.kccllc.net/wamu/document/0812229180717000000000001
1/1/18 – 8/31/18 $726,925.94
http://www.kccllc.net/wamu/document/0812229181008000000000001
1/1/18 – 11/30/18 $1,288,306.31
http://www.kccllc.net/wamu/document/0812229190129000000000001
11/1/18 – 2/28/19 $1,121,582.79
http://www.kccllc.net/wamu/document/0812229190423000000000001
02/01/19 – 05/31/19 $1,484,645.50
http://www.kccllc.net/wamu/document/0812229190724000000000001
04/01/19 – 08/31/19 $1,188,732.58
http://www.kccllc.net/wamu/document/0812229191031000000000004
= $88,237,146.73
------------------------------------------------------------------
Total fee expenses for the periods covered between 09/26/08 to 08/31/19
$271,085,212.87 + $88,237,146.73 = $359,322,359.60
The Underwriters want to keep what they were given many years ago, 1.4 million WMIH shares.
Rosen stated in reply to Alice's filing that if she were to prevail then the Underwriters would have to give up those shares, assuming they still had them. If not, they would have to pay the cash equivalent to those shares.
It's really not that hard to understand why they want to remain in Class 19!